Dr. Zorina Tatiana Zorina, MD, PhD, CT(ASCP)

Contact Dr. Zorina

130 South 9th Street
Suite 1924
Philadelphia, PA 19107

(215) 503-8182
(215) 503-2189 fax

Education
PhD Immunology, Institute of Experimental Medicine, St. Petersburg, Russia, 1987
MD Internal Medicine, University of St. Petersburg, St. Petersburg, Russia, 1974
Certificate Cytology, University of Pittsburgh Medical Center, Pittsburgh, PA, 2005

Certification
CT(ASCP) #CT-014006, 2011
Cytotechnologist, CA License ID: CLM1249, 2011
ThinPrep Pap Test Training Program Ceritficate, Anisa I. Kanbour School of Cytology, UPMC, Pittsburgh, PA, 2005
ThinPrep Imaging System Review Scope Training Program Certificate, Anisa I. Kanbour School of Cytology, UPMC, Pittsburgh, PA, 2006

Research and Clinical Interests
T regulatory cells trafficking in Type 1 Diabetes
Gene and Cell Based Approaches for abrogation of Autoimmunity in Type 1 Diabetes

Professional Societies
American Society for Clinical Pathology, 2005- present
American Society of Cytopathology, 2009-present

Publications

Most recent Peer-reviewed Publications

  1. Treg cells in pancreatic lymph nodes: The possible role in diabetogenesis and β cell regeneration in a T1D model
  2. Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand
  3. Recovery of the endogenous β cell function in the NOD model of autoimmune diabetes
  4. Transplanted hematopoietic cells seed in clusters in recipient bone marrow in vivo
  5. Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes
  6. Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mi Kinetics and repopulating potential
  7. Development of dendritic cell-based genetic vaccines for cancer
  8. FLT3 ligand induces the generation of functionally active dendritic cells in mice
  9. Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines
  10. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
  11. The effect of the bone marrow fibroblasts from patients with malignant diseases of the blood system on the colony-forming capacity of granulomonocytic precursor cells | Vliianie fibroblastov kostnogo mozga bol'nykh zlokachestvennymi zabolevaniiami sistemy krovi na kolonieobrazuiushchuiu sposobnost' granulomonotsitarnykh kletok-predshestvennikov.